The Joint Statistics
Total Valuation
The Joint has a market cap or net worth of $114.34 million. The enterprise value is $95.56 million.
| Market Cap | 114.34M |
| Enterprise Value | 95.56M |
Important Dates
The next confirmed earnings date is Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
The Joint has 13.69 million shares outstanding. The number of shares has decreased by -0.65% in one year.
| Current Share Class | 13.69M |
| Shares Outstanding | 13.69M |
| Shares Change (YoY) | -0.65% |
| Shares Change (QoQ) | -2.71% |
| Owned by Insiders (%) | 16.38% |
| Owned by Institutions (%) | 37.24% |
| Float | 6.62M |
Valuation Ratios
The trailing PE ratio is 39.04 and the forward PE ratio is 18.33.
| PE Ratio | 39.04 |
| Forward PE | 18.33 |
| PS Ratio | 2.02 |
| Forward PS | 1.87 |
| PB Ratio | 7.39 |
| P/TBV Ratio | 7.38 |
| P/FCF Ratio | 43.00 |
| P/OCF Ratio | 28.11 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 161.51, with an EV/FCF ratio of 35.98.
| EV / Earnings | 29.51 |
| EV / Sales | 1.69 |
| EV / EBITDA | 161.51 |
| EV / EBIT | n/a |
| EV / FCF | 35.98 |
Financial Position
The company has a current ratio of 1.64, with a Debt / Equity ratio of 0.13.
| Current Ratio | 1.64 |
| Quick Ratio | 0.76 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 3.45 |
| Debt / FCF | 0.77 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 7.00% and return on invested capital (ROIC) is 1.97%.
| Return on Equity (ROE) | 7.00% |
| Return on Assets (ROA) | 0.61% |
| Return on Invested Capital (ROIC) | 1.97% |
| Return on Capital Employed (ROCE) | -4.10% |
| Weighted Average Cost of Capital (WACC) | 10.09% |
| Revenue Per Employee | $171,631 |
| Profits Per Employee | $9,814 |
| Employee Count | 330 |
| Asset Turnover | 0.82 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, The Joint has paid $36,361 in taxes.
| Income Tax | 36,361 |
| Effective Tax Rate | 2.64% |
Stock Price Statistics
The stock price has decreased by -26.71% in the last 52 weeks. The beta is 1.09, so The Joint's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -26.71% |
| 50-Day Moving Average | 8.85 |
| 200-Day Moving Average | 8.79 |
| Relative Strength Index (RSI) | 40.68 |
| Average Volume (20 Days) | 84,472 |
Short Selling Information
The latest short interest is 472,441, so 3.45% of the outstanding shares have been sold short.
| Short Interest | 472,441 |
| Short Previous Month | 470,910 |
| Short % of Shares Out | 3.45% |
| Short % of Float | 7.14% |
| Short Ratio (days to cover) | 2.79 |
Income Statement
In the last 12 months, The Joint had revenue of $56.64 million and earned $3.24 million in profits. Earnings per share was $0.21.
| Revenue | 56.64M |
| Gross Profit | 45.66M |
| Operating Income | 670,078 |
| Pretax Income | 1.38M |
| Net Income | 3.24M |
| EBITDA | 591,685 |
| EBIT | -1.14M |
| Earnings Per Share (EPS) | $0.21 |
Balance Sheet
The company has $20.68 million in cash and $2.04 million in debt, with a net cash position of $18.64 million or $1.36 per share.
| Cash & Cash Equivalents | 20.68M |
| Total Debt | 2.04M |
| Net Cash | 18.64M |
| Net Cash Per Share | $1.36 |
| Equity (Book Value) | 15.49M |
| Book Value Per Share | 1.13 |
| Working Capital | 19.42M |
Cash Flow
In the last 12 months, operating cash flow was $4.06 million and capital expenditures -$1.41 million, giving a free cash flow of $2.66 million.
| Operating Cash Flow | 4.06M |
| Capital Expenditures | -1.41M |
| Depreciation & Amortization | 1.68M |
| Net Borrowing | n/a |
| Free Cash Flow | 2.66M |
| FCF Per Share | $0.19 |
Margins
Gross margin is 80.62%, with operating and profit margins of 1.18% and 5.72%.
| Gross Margin | 80.62% |
| Operating Margin | 1.18% |
| Pretax Margin | 2.43% |
| Profit Margin | 5.72% |
| EBITDA Margin | 1.04% |
| EBIT Margin | -2.01% |
| FCF Margin | 4.69% |
Dividends & Yields
The Joint does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.65% |
| Shareholder Yield | 0.65% |
| Earnings Yield | 2.84% |
| FCF Yield | 2.33% |
Analyst Forecast
The average price target for The Joint is $10.00, which is 19.76% higher than the current price. The consensus rating is "Hold".
| Price Target | $10.00 |
| Price Target Difference | 19.76% |
| Analyst Consensus | Hold |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
The Joint has an Altman Z-Score of 2.94 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.94 |
| Piotroski F-Score | 6 |